Levothyroxine Sodium Tablet
Product Images NDC 51655-484

3 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)
Chemical structure of Levothyroxine Sodium showing iodine-substituted phenyl rings connected to an amino acid moiety with carboxylate sodium salt and variable hydration (xH2O).*
FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)
FDA Label Image

Label (51655 484 52 Rev B 05 22 Nhc)

Label (51655 484 52 Rev B 05 22 Nhc)
Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) tablet label showing a 30-tablet package. The label includes dosage instructions, storage conditions, and manufacturer information for Northwind Health Company, LLC. The label lists the product as prescription only and includes a lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.